Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
| Other author | Center for Drug Evaluation and Research (U.S.) |
| Other author | Center for Biologics Evaluation and Research (U.S.) |
| Format | Electronic |
| Publication Info | [Rockville, MD] : Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [1995] |
| Description | 1 online resource (i, 16 p.) |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS118486 |
| Subjects |
| Portion of title | Content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products |
| General note | "November 1995." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references (p. 15-16). |
| Issued in other form | Print version: Guidance for industry |
| GPO item number | 0499-T (online) |
| Govt. docs number | HE 20.4702:IN 8 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |